Renal Cancer - Results from #5140

Current management of metastatic renal cell carcinoma: evolving new therapies June 16, 2017

Renal cell carcinoma with synchronous ipsilateral urothelial carcinoma of the renal pelvis June 16, 2017

Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Carcinoma Extracranial Metastases June 16, 2017

Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. June 15, 2017

Current Clinical Practice Guidelines for the Treatment of Renal Cell Carcinoma: A Systematic Review and Critical Evaluation. June 15, 2017

Intratumor cisplatin nephrotoxicity in combined laser-induced thermal therapy for cancer treatment June 14, 2017

Genome-wide association study identifies multiple risk loci for renal cell carcinoma June 14, 2017

Clear Cell Renal Cell Carcinoma is linked to Epithelial-to-Mesenchymal Transition and to Fibrosis June 14, 2017

Integrating Immunotherapy Into the Management of Renal Cell Carcinoma June 14, 2017

[Is nephron-sparing surgery relevant for unilateral Wilms tumors?] June 12, 2017

Patient-specific molecular alterations are associated with metastatic clear cell renal cell cancer progressing under tyrosine kinase inhibitor therapy June 12, 2017

Factors possibly affecting prognosis in children with Wilms' tumor diagnosed before 24 months of age: A report from the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) Wilms Tumor Working Group June 12, 2017

Everolimus-induced pneumonitis associates with favourable outcome in patients with metastatic renal cell carcinoma June 9, 2017

Prognostic significance of promoter CpG island methylation of obesity-related genes in patients with nonmetastatic renal cell carcinoma. June 5, 2017

Clinical Features of Nivolumab-Induced Thyroiditis: A Case Series Study June 2, 2017

The renal safety and efficacy of combined gemcitabine plus cisplatin and gemcitabine plus carboplatin chemotherapy in Chinese patients with a solitary kidney after nephroureterectomy June 2, 2017

Increased serum level of soluble interleukin-2 receptor is associated with a worse response of metastatic clear cell renal cell carcinoma to interferon alpha and sequential VEGF-targeting therapy June 1, 2017

Preoperative cholesterol level as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with cyto-reductive nephrectomy June 1, 2017

The genetic factors contributing to the development of Wilm's tumor and their clinical utility in its diagnosis and prognosis June 1, 2017

Metastatic chromophobe renal cell carcinoma treated with targeted therapies: A Renal Cross Channel Group study. May 31, 2017

Page 258 of 456